News

OGE Energy (OGE) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the

Enpro (NPO) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the

Mueller Water Products (MWA) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting

Loar Holdings Inc. (LOAR) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might continue

Trip.com (TCOM) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a growth

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. However, it isn't easy to

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. However, it isn't easy to

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a growth

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock

Photronics (PLAB) closed the last trading session at $22.64, gaining 12% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Shares of Inogen (INGN) have gained 25.2% over the past four weeks to close the last trading session at $8.11, but there could still be a solid upside left in the stock if short-term price targets

Phathom Pharmaceuticals, Inc. (PHAT) closed the last trading session at $12.34, gaining 26.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price

Epam (EPAM) closed the last trading session at $169.46, gaining 7.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

Shares of Ategrity Specialty Insurance Company Holdings (ASIC) have gained 11.6% over the past four weeks to close the last trading session at $21.3, but there could still be a solid upside left in

Shares of Aligos Therapeutics, Inc. (ALGS) have gained 47.5% over the past four weeks to close the last trading session at $11.34, but there could still be a solid upside left in the stock if

Shares of Mersana Therapeutics, Inc. (MRSN) have gained 8.3% over the past four weeks to close the last trading session at $6.82, but there could still be a solid upside left in the stock if

Shares of Red Robin (RRGB) have gained 8.6% over the past four weeks to close the last trading session at $6.17, but there could still be a solid upside left in the stock if short-term price targets

DiaMedica Therapeutics, Inc. (DMAC) closed the last trading session at $6.14, gaining 31.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price

Shares of Salesforce.com (CRM) have gained 4.3% over the past four weeks to close the last trading session at $250.76, but there could still be a solid upside left in the stock if short-term price